Mark E. Saad - 06 Jun 2025 Form 4 Insider Report for Axsome Therapeutics, Inc. (AXSM)

Role
Director
Signature
/s/ Nick Pizzie, Attorney-in-Fact
Issuer symbol
AXSM
Transactions as of
06 Jun 2025
Net transactions value
$0
Form type
4
Filing time
10 Jun 2025, 19:00:06 UTC
Previous filing
25 Feb 2025
Next filing
05 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Saad Mark E Director C/O AXSOME THERAPEUTICS, INC., ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK /s/ Nick Pizzie, Attorney-in-Fact 10 Jun 2025 0001295913

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXSM Stock Option (Right to Buy) Award $0 +3,166 $0.000000 3,166 06 Jun 2025 Common Stock 3,166 $111.91 Direct F1
transaction AXSM Restricted Stock Units Award $0 +1,429 $0.000000 1,429 06 Jun 2025 Common Stock 1,429 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest in full on the one-year anniversary of the date of grant, June 6, 2026.
F2 Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
F3 The RSUs vest in full on the one-year anniversary of the date of grant, June 6, 2026.